BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16495774)

  • 1. Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophrenia.
    Liou YJ; Lai IC; Lin MW; Bai YM; Lin CC; Liao DL; Chen JY; Lin CY; Wang YC
    Pharmacogenet Genomics; 2006 Mar; 16(3):151-7. PubMed ID: 16495774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    J Diabetes Complications; 2008; 22(5):331-8. PubMed ID: 18413207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
    Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
    Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene polymorphisms and the risk of ischemic stroke.
    Saidi S; Mallat SG; Almawi WY; Mahjoub T
    Acta Neurol Scand; 2010 Feb; 121(2):114-9. PubMed ID: 19804474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension.
    Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Sikdar S; Gupta M; Javed S; Pasha MA
    Free Radic Biol Med; 2008 Jun; 44(11):1912-8. PubMed ID: 18325347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):542-6. PubMed ID: 17973941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy.
    Sandrim VC; Yugar-Toledo JC; Desta Z; Flockhart DA; Moreno H; Tanus-Santos JE
    J Hypertens; 2006 Dec; 24(12):2393-7. PubMed ID: 17082721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of genetic polymorphisms in endothelial nitric oxide synthase 3 gene with recurrent early spontaneous abortion].
    Fan W; Li SW; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):23-6. PubMed ID: 17285538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients.
    Kang SG; Choi JE; An H; Lim SW; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Lee MS; Joe SH; Jung IK; Kim L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1545-8. PubMed ID: 18602732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.
    Riener EK; Hefler LA; Grimm C; Galid A; Zeillinger R; Tong-Cacsire D; Gitsch G; Leodolter S; Tempfer CB
    Gynecol Oncol; 2004 Jun; 93(3):686-90. PubMed ID: 15196865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
    Zai CC; Tiwari AK; Basile V; De Luca V; Müller DJ; King N; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Pharmacogenomics J; 2009 Jun; 9(3):168-74. PubMed ID: 19238168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype analysis of the endothelial nitric oxide synthase gene in asthma.
    Holla LI; Jurajda M; Pohunek P; Znojil V
    Hum Immunol; 2008; 69(4-5):306-13. PubMed ID: 18486767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
    Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias.
    Pereira TV; Rudnicki M; Cheung BM; Baum L; Yamada Y; Oliveira PS; Pereira AC; Krieger JE
    J Hypertens; 2007 Sep; 25(9):1763-74. PubMed ID: 17762636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.